Arkolith/Insider Trading/CKPT/Form 4

Oliviero James F III

CEO, President and Director, DirectorCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed Mar 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$53K
Net Open-Market Flow
-$53K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2023Sell(S)5K$5.00$27K144K
Feb 27, 2023Grant(A)15K—$0150K
Feb 27, 2023Sell(S)6K$4.65$26K135K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-028603) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML